Joseph Newman, PhD, MS

Visiting Associate Professor Department of Biomedical Sciences | College of Dentistry
Contact Groups and Affiliations

Biography

Career History

  • Director Flow Cytometry, Medfusion/Quest Diagnostics, Lewisville, TX 75067 (2017-2019)
  • Technical Director Flow Cytometry, Medfusion, Lewisville, TX 75067 (2011-2017)
  • Associate Director of Virology, Department of Pathology, Baylor University Medical Center, Dallas, TX (1990-2000)
  • Acting Director of Virology, Department of Pathology, Baylor University Medical Center, Dallas, TX (1982-1989)
  • Associate Director of Immunology, Department of Pathology, Baylor University Medical Center, Dallas, TX (1975-2011)
  • Microbiologist-Immunologist, Department of Pathology, Baylor University Medical Center, Dallas, TX (1974-1982)
  • Postdoctoral Fellowship, Department of Microbiology, University of Texas Health Science Center, San Antonio (1972-1974)
  • Teaching Assistant, Department of Microbiology, University of Texas Health Science Center, San Antonio (1970-1972)
  • Biologist, Meloy Laboratory, Springfield, VA (1967-1969)
  • Bacteriologist, Department of Agricultural Engineering, University of Connecticut, Storrs, Ct (1965-1966)

Education

  • Postdoctoral Fellowship, Department of Microbiology University of Texas Health Science Center, San Antonio, TX; 1972-1974
  • Ph.D., Microbiology University of Texas Health Science Center, San Antonio, TX; 1969-1973
  • M.S., Bacteriology University of Connecticut, Storrs, CT; 1962-1966
  • A.B., Biology St. Michael's College, Winooski, VT; 1958-1962

Teaching Interests

  • Microbiology (Immunology/Virology – dental and graduate students)

Publications

2009 Growth inhibition of human multiple myeloma cells by an oncolytic adenovirus carrying the CD40 ligand (CD40L) transgene.
Fernandes, M.S., Gomes, E.M.,Butcher, L.D., Hernandez-Alcoceba, R., Chang, J., Kansopon, J., Newman, J., Stone, M.J. & Tong, A.W. Growth inhibition of human multiple myeloma cells by an oncolytic adenovirus carrying the CD40 ligand (CD40L) transgene. Clin Cancer Res 15:4847-56, 2009.
1999 In vitro alteration of macrophage phenotype and function by serum lipids.
Chu, X., Newman, J., Park, B., Nares, S., Ordonez, G., Iacopino, A.M. In vitro alteration of macrophage phenotype and function by serum lipids. Cell Tissue Res 296:331-337, 1999.
1999 Crystalloid cytoplasmic inclusions in myeloma marrow
Phillips, S.D., Newman, J.T., Stone, M.J. Crystalloid cytoplasmic inclusions in myeloma marrow. Photograph. Blood 94:913, 1999.
2000 Serologic prevalence of antibody to human herpes virus type 8 in patients with various monoclonal gammopathies.
Stone, S.A., Lennette, E.T., Newman, J.T., Burfoot, A., Stone, M.J. Serologic prevalence of antibody to human herpes virus type 8 in patients with various monoclonal gammopathies. Leukemia and Lymphoma 37:197-203, 2000.
2000 Liver allotransplantation after extracorporeal hepatic support with transgenic (hCD55/CD59) porcine livers.
Levy, M.F., Crippin, F., Sutton, S., Netto, G., McCormack, J., Curial, T., Goldstein, R.M., Newman, J.T., Gonwa, T.A., Banchereau, J., Diamond, L.E., Byrne, G., Logan, J., Klintmalm, G.B. Liver allotransplantation after extracorporeal hepatic support with transgenic (hCD55/CD59) porcine livers. Transplantation 69:272-280, 2000.
2001 The effect of FIV infection on CD4+ and CD8+ counts in periradicular lesions.
Levine, D.F., Witherspoon, D.E., Gutmann, J.L., Nunn, M.E., Newman, J.T., Iacopino, A.M. The effect of FIV infection on CD4+ and CD8+ counts in periradicular lesions. Int Endod J 34(8): 586-593, 2001.
2003 Human monoclonal macroglobulins with antibody activity.
Stone, M.J., McElroy, Y.G., Pestronk, A., Reynolds, J.L., Newman, J.T., Tong, A.W. Human monoclonal macroglobulins with antibody activity. Seminars in Oncology 30:318-324, 2003.
2005 Evaluation of molecular features and cytokine expression.
Konduri K., Sahota S.S., Babbage G., Tong, A.W., Kumar, P., Newman, J.T., Stone, M.J. Immonoglobulin M myeloma: Evaluation of molecular features and cytokine expression. Clin lymphoma 5(4): 285-289, 2005.